Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Published in: PharmacoEconomics 6/1997

01-06-1997 | Original Research Article

Incremental Cost-Effectiveness Ratio of Alteplase in Patients with Acute Myocardial Infarction in the French Setting

Authors: Mr Alain Pelc, Jacques Dardenne, Jean-Hughes Frelon, Guy Hanania

Published in: PharmacoEconomics | Issue 6/1997

Login to get access
Metadata
Title
Incremental Cost-Effectiveness Ratio of Alteplase in Patients with Acute Myocardial Infarction in the French Setting
Authors
Mr Alain Pelc
Jacques Dardenne
Jean-Hughes Frelon
Guy Hanania
Publication date
01-06-1997
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 6/1997
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-199711060-00007

Other articles of this Issue 6/1997

PharmacoEconomics 6/1997 Go to the issue

Erratum

Erratum to Will Managed Care Work in Europe?

Original Research Article

Some Aspects of the Cost of Schizophrenia in France

Leading Article

The Generalisability of Pharmacoeconomic Studies

Original Research Article

A Pharmacoeconomic Analysis of Patients with Symptoms of Benign Prostatic Hyperplasia

Review Article

Constraints on Antidepressant Prescribing and Principles of Cost-Effective Antidepressant Use

Correspondence

Cost Effectiveness and Allocation of Therapies in a Treating Population: The Author’s Reply